Genetics Department, Federal University of Parana, 81531-970 Curitiba, PR, Brazil.
Hum Pathol. 2012 Oct;43(10):1661-7. doi: 10.1016/j.humpath.2011.12.008. Epub 2012 Apr 13.
The 2 main histologic types of infiltrating breast cancer, invasive lobular and invasive ductal carcinoma, are morphologically and clinically distinct. Studies revealed that different patterns of gene expression and loss of heterozygosity can also distinguish these 2 subtypes. A whole-genome study using single nucleotide polymorphism array found a significantly higher frequency of loss of heterozygosity on 3p in invasive ductal carcinoma when compared with invasive lobular carcinoma. In this study, we performed a loss of heterozygosity analysis of the 3p chromosome region in ductal and lobular breast tumors. Seven microsatellite markers were evaluated in a series of 136 sporadic breast cancer cases (118 invasive ductal carcinoma and 18 invasive lobular carcinoma) and correlated with clinical-histopathologic parameters from the patients. A significantly higher frequency of loss of heterozygosity was observed in invasive ductal carcinoma (65.3%) when compared with invasive lobular carcinoma (38.9%). When the markers were analyzed separately, loss of heterozygosity at 3 of them, D3S1307 in 3p26.3, D3S1286 in 3p24.3, and D3S1300 in 3p14.2, were significantly more frequent in ductal than in lobular tumors. D3S1307 marker showed the highest frequency of loss of heterozygosity in invasive ductal carcinoma (46.2%), and associations between loss of this marker and loss of estrogen and progesterone receptors were found in these samples. Our results confirm the observations that invasive ductal carcinoma has a higher frequency of loss of heterozygosity events across the 3p region than invasive lobular carcinoma and show that specific losses on 3p26.3, 3p24.3, and 3p14.2 regions are more frequent in ductal than in lobular tumors. We discuss our data in relation to the known tumor suppressor genes that are mapped at the 3p loci investigated and their present relevant roles in breast cancer.
浸润性乳腺癌的 2 种主要组织学类型,浸润性小叶癌和浸润性导管癌,在形态学和临床上是不同的。研究表明,不同的基因表达模式和杂合性丢失也可以区分这 2 种亚型。一项使用单核苷酸多态性阵列的全基因组研究发现,与浸润性小叶癌相比,浸润性导管癌中 3p 上的杂合性丢失频率明显更高。在这项研究中,我们对导管癌和小叶癌中的 3p 染色体区域进行了杂合性丢失分析。在一系列 136 例散发性乳腺癌病例(118 例浸润性导管癌和 18 例浸润性小叶癌)中评估了 7 个微卫星标记,并与患者的临床病理参数相关。与浸润性小叶癌(38.9%)相比,浸润性导管癌(65.3%)的杂合性丢失频率明显更高。当单独分析这些标记时,在 3 个标记(3p26.3 上的 D3S1307、3p24.3 上的 D3S1286 和 3p14.2 上的 D3S1300)中,导管癌的杂合性丢失频率明显高于小叶癌。D3S1307 标记在浸润性导管癌中显示出最高的杂合性丢失频率(46.2%),并且在这些样本中发现了该标记与雌激素和孕激素受体丢失之间的关联。我们的结果证实了浸润性导管癌在 3p 区域的杂合性丢失事件频率高于浸润性小叶癌的观察结果,并表明在导管癌中,3p26.3、3p24.3 和 3p14.2 区域的特定缺失比小叶癌更常见。我们根据已知映射到研究的 3p 位点的肿瘤抑制基因及其在乳腺癌中的当前相关作用,讨论了我们的数据。